請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/70997
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳宏文(Hung-Wen Chen) | |
dc.contributor.author | Ming-Ren Yang | en |
dc.contributor.author | 楊明仁 | zh_TW |
dc.date.accessioned | 2021-06-17T04:47:38Z | - |
dc.date.available | 2018-08-13 | |
dc.date.copyright | 2018-08-13 | |
dc.date.issued | 2018 | |
dc.date.submitted | 2018-08-01 | |
dc.identifier.citation | 1. Gude, N.M., et al., Growth and function of the normal human placenta. Thromb Res, 2004. 114(5-6): p. 397-407.
2. Cross, J.C., Placental function in development and disease. Reprod Fertil Dev., 2006. 18(1-2): p. 71-6. 3. Bischof, P. and I. Irminger-Finger, The human cytotrophoblastic cell, a mononuclear chameleon. Int J Biochem Cell Biol, 2005. 37(1): p. 1-16. 4. Handwerger, S., New insights into the regulation of human cytotrophoblast cell differentiation. Mol Cell Endocrinol, 2010. 323(1): p. 94-104. 5. Huppertz, B. and M. Borges, Placenta trophoblast fusion. Methods Mol Biol, 2008. 475: p. 135-47. 6. Lunghi, L., et al., Control of human trophoblast function. Reprod Biol Endocrinol, 2007. 5: p. 6. 7. Cross, J.C., et al., Genes, Development and Evolution of the Placenta. Placenta, 2003. 24(2-3): p. 123-130. 8. BW, J., et al., glial cells missing: a genetic switch that controls glial versus neuronal fate. 1995. 82(6): p. 1013-23. 9. T, H., et al., glial cells missing: a binary switch between neuronal and glial determination in Drosophila. Cell, 1995. 82(6): p. 1025-1036. 10. Wegner, M. and D. Riethmacher, Chronicles of a switch hunt: gcm genes in development. Trends Genet, 2001. 17(5): p. 286-90. 11. Kanemura, Y., et al., Isolation and expression analysis of a novel human homologue of the Drosophila glial cells missing (gcm) gene. FEBS Letters 1999. 442(2-3): p. 151-156. 12. Kim, J., et al., Isolation and Characterization of Mammalian Homologs of the Drosophila Gene glial cells missing. Proc Natl Acad Sci U S A, 1998. 95(21): p. 12364-9. 13. Cohen, S.X., et al., Structure of the GCM domain-DNA complex: a DNA-binding domain with a novel fold and mode of target site recognition. EMBO J, 2003. 22(8): p. 1835-45. 14. L, A.-C., et al., The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat Genet, 2000. 25(3): p. 311-4. 15. Schreiber , J., et al., Placental Failure in Mice Lacking the Mammalian Homolog of Glial Cells Missing, GCMa. Mol Cell Biol, 2000. 20(7): p. 2466-74. 16. Günther, T., et al., Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature, 2000. 406(6792): p. 199-203. 17. Desai, J., et al., Signal transduction and biological function of placenta growth factor in primary human trophoblast. Biol Reprod, 1999. 60(4): p. 887-92. 18. Ding, C., B. Buckingham, and M.A. Levine, Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB. Journal of Clinical Investigation, 2001. 108(8): p. 1215-1220. 19. Rawn, S.M. and J.C. Cross, The evolution, regulation, and function of placenta-specific genes. Annu Rev Cell Dev Biol., 2008. 24: p. 159-81. 20. Baczyk, D., et al., Glial cell missing-1 transcription factor is required for the differentiation of the human trophoblast. Cell Death Differ, 2009. 16(5): p. 719-27. 21. Yamada, K., et al., A GCM Motif Protein Is Involved in Placenta-specific Expression of Human Aromatase Gene. J Biol Chem, 1999. 274(45): p. 32279-86. 22. Yu, C., et al., GCMa regulates the syncytin-mediated trophoblastic fusion. J Biol Chem, 2002. 277(51): p. 50062-8. 23. Malassine, A., et al., Expression of the fusogenic HERV-FRD Env glycoprotein (syncytin 2) in human placenta is restricted to villous cytotrophoblastic cells. Placenta, 2007. 28(2-3): p. 185-91. 24. Esnault, C.c., et al., A placenta-specific receptor for the fusogenic, endogenous retrovirus-derived, human syncytin-2. Proc Natl Acad Sci U S A, 2008. 105(45): p. 17532-7. 25. Chen, C.P., et al., Functional characterization of the human placental fusogenic membrane protein syncytin 2. Biol Reprod, 2008. 79(5): p. 815-23. 26. Vargas, A., et al., Syncytin-2 plays an important role in the fusion of human trophoblast cells. J Mol Biol, 2009. 392(2): p. 301-18. 27. Liang, C.Y., et al., GCM1 regulation of the expression of syncytin 2 and its cognate receptor MFSD2A in human placenta. Biol Reprod, 2010. 83(3): p. 387-95. 28. Wang, L.J., et al., High-temperature requirement protein A4 (HtrA4) suppresses the fusogenic activity of syncytin-1 and promotes trophoblast invasion. Mol Cell Biol, 2012. 32(18): p. 3707-17. 29. Chang, C.W., G.D. Chang, and H. Chen, A novel cyclic AMP/Epac1/CaMKI signaling cascade promotes GCM1 desumoylation and placental cell fusion. Mol Cell Biol, 2011. 31(18): p. 3820-31. 30. Chang, C.W., et al., Stimulation of GCMa transcriptional activity by cyclic AMP/protein kinase A signaling is attributed to CBP-mediated acetylation of GCMa. Mol Cell Biol, 2005. 25(19): p. 8401-14. 31. Chou, C.C., et al., Small ubiquitin-like modifier modification regulates the DNA binding activity of glial cell missing Drosophila homolog a. J Biol Chem, 2007. 282(37): p. 27239-49. 32. Maglione, D., et al., Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. USA, 1991. 88(20): p. 9267-9271. 33. Iyer, S., et al., The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution. J Biol Chem, 2001. 276(15): p. 12153-61. 34. Cao, Y., et al., Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. Biochem Biophys Res Commun, 1997. 235(3): p. 493-8. 35. Park, J.E., et al., Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem, 1994. 1994(269): p. 41. 36. Migdal, M., et al., Neuropilin-1 Is a Placenta Growth Factor-2 Receptor. J Biol Chem, 1998. 273(35): p. 22272-8. 37. Yang, W., et al., Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human trophoblast and endothelial cells. Journal of Reproductive Immunology, 2003. 60(1): p. 53-60. 38. Yajima, I., et al., Arsenite-mediated promotion of anchorage-independent growth of HaCaT cells through placental growth factor. J Invest Dermatol, 2015. 135(4): p. 1147-1156. 39. Tchaikovski, V., G. Fellbrich, and J. Waltenberger, The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes. Arterioscler Thromb Vasc Biol, 2008. 28(2): p. 322-8. 40. CARMELIET, P., et al., Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med, 2001. 7(5): p. 575-83. 41. Gigante, B., et al., Placenta growth factor is not required for exercise-induced angiogenesis. Angiogenesis, 2004. 2004(7): p. 3. 42. Ziche, M., et al., Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invest, 1997. 76(4): p. 517-31. 43. Yonekura, H., et al., Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis. J Biol Chem, 1999. 274(49): p. 35172-8. 44. Failla, C.M., et al., Placenta growth factor is induced in human keratinocytes during wound healing. J Invest Dermatol, 2000. 115(3): p. 388-95. 45. Selvaraj, S.K., et al., Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood, 2003. 102(4): p. 1515-24. 46. Lin, Y.L., Y.C. Liang, and B.L. Chiang, Placental growth factor down-regulates type 1 T helper immune response by modulating the function of dendritic cells. J Leukoc Biol, 2007. 82(6): p. 1473-80. 47. Adini, A., et al., Placental Growth Factor Is a Survival Factor for Tumor Endothelial Cells and Macrophages. Cancer Res, 2002. 62(10): p. 2749-52. 48. Rolny, C., et al., HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell, 2011. 19(1): p. 31-44. 49. Van de Veire, S., et al., Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell, 2010. 141(1): p. 178-90. 50. Roncal, C., et al., Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions. Cardiovasc Res, 2010. 86(1): p. 29-36. 51. Yoo, S.A., et al., Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation. Arthritis Rheum, 2009. 60(2): p. 345-54. 52. Patel, N., et al., Placenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD). J Biol Chem, 2010. 285(22): p. 16713-22. 53. Munaut, C., et al., Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast. Hum Reprod, 2008. 23(6): p. 1407-15. 54. Depoix, C., M.K. Tee, and R.N. Taylor, Molecular regulation of human placental growth factor (PlGF) gene expression in placental villi and trophoblast cells is mediated via the protein kinase a pathway. Reprod Sci, 2011. 18(3): p. 219-28. 55. Tayade, C., et al., Genetic Deletion of Placenta Growth Factor in Mice Alters Uterine NK Cells. The Journal of Immunology, 2007. 178(7): p. 4267-4275. 56. Cohen, S.M., et al., Distal-less encodes a homoeodomain protein required for limb development in Drosophila. Nature, 1989. 338(6214): p. 432-4. 57. Quinn, L.M., S.E. Latham, and B. Kalionisa, A Distal-less Class Homeobox Gene, DLX4, is a Candidate for Regulating Epithelial-Mesenchymal Cell Interactions in the Human Placenta Placenta, 1998. 19(1): p. 87-93. 58. Simeone, A., et al., Cloning and characterization of two members of the vertebrate Dlx gene family. Proc. NatI. Acad. Sci. USA, 1994. 91(6): p. 2250-4. 59. Nakamura, S., et al., Genomic Analysis of a New Mammalian Distal-less Gene: Dlx7. GENOMICS, 1996. 38(3): p. 314-24. 60. Ozçelik, T., et al., DLX2 (TES1), a homeobox gene of the Distal-less family, assigned to conserved regions on human and mouse chromosomes 2. Genomics, 1992. 13(4): p. 1157-61. 61. E, R., et al., Order of six loci at 2q24-q31 and orientation of the HOXD locus. Genomics, 1994. 24(1): p. 34-40. 62. Bryan, J.T. and M.I. Morasso, The Dlx3 protein harbors basic residues required for nuclear localization, transcriptional activity and binding to Msx1. J Cell Sci, 2000. 113(22): p. 4013-23. 63. Feledy, J.A., et al., Transcriptional activation by the homeodomain protein Distal-less 3. Nucleic Acids Res. , 1999. 27(3): p. 764-70. 64. Billeter, M., et al., Determination of the three-dimensional structure of the Antennapedia homeodomain from Drosophila in solution by 1H nuclear magnetic resonance spectroscopy. J Mol Biol., 1990. 214(1): p. 183-97. 65. Gehring, W.J., et al., The structure of the homeodomain and its functional implications. Trends Genet., 1990. 6(10): p. 323-9. 66. Robinson, G.W. and K.A. Mahon, Differential and overlapping expression domains of Dlx-2 and Dlx-3 suggest distinct roles for Distal-less homeobox genes in craniofacial development Mech Dev, 1994. 48(3): p. 199-215. 67. Morasso, M.I., M. Jamrich, and T.D. Sargent, The homeodomain gene Xenopus Distal-less-like-2 (Xdll-2) is regulated by a conserved mechanism in amphibian and mammalian epidermis. Dev Biol, 1994. 162(1): p. 267-76. 68. Morasso, M.I., N.G. Markova, and T.D. Sargent, Regulation of Epidermal Differentiation by a Distal-less Homeodomain Gene. J Cell Biol., 1996. 135(6 Pt 2): p. 1879-87. 69. Qiu, M., et al., Role of the Dlx homeobox genes in proximodistal patterning of the branchial arches: mutations of Dlx-1, Dlx-2, and Dlx-1 and -2 alter morphogenesis of proximal skeletal and soft tissue structures derived from the first and second arches. Dev Biol., 1997. 185(2): p. 165-84. 70. Price, J.A., et al., Identification of a mutation in DLX3 associated with tricho-dento-osseous (TDO) syndrome. Hum Mol Genet., 1998. 7(3): p. 563-9. 71. Nieminen, P., et al., DLX3 homeodomain mutations cause tricho-dento-osseous syndrome with novel phenotypes. Cells Tissues Organs, 2011. 194(1): p. 49-59. 72. Scherer , S.W., et al., Assignment of the human homolog of mouse Dlx3 to chromosome 17q21.3-q22 by analysis of somatic cell hybrids and fluorescence in situ hybridization. Mamm Genome, 1995. 6(4): p. 310–311. 73. Price, J.A., et al., A common DLX3 gene mutation is responsible for tricho-dento-osseous syndrome in Virginia and North Carolina families. J Med Genet, 1998. 35(10): p. 825-8. 74. Dong, J., et al., DLX3 mutation associated with autosomal dominant amelogenesis imperfecta with taurodontism. Am J Med Genet A, 2005. 133A(2): p. 138-41. 75. Lee, S.-K., et al., DLX3 Mutation in a New Family and Its Phenotypic Variations. J Dent Res, 2008. 87(4): p. 354-357. 76. Wright, J.T., et al., DLX3 c.561_562delCT mutation causes attenuated phenotype of tricho-dento-osseous syndrome. Am J Med Genet A, 2008. 146A(3): p. 343-9. 77. Haldeman, R.J., et al., Increased bone density associated with DLX3 mutation in the tricho-dento-osseous syndrome. Bone, 2004. 35(4): p. 988-97. 78. Hassan, M.Q., et al., Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol Cell Biol, 2004. 24(20): p. 9248-61. 79. Hassan, M.Q., et al., BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network. J Biol Chem, 2006. 281(52): p. 40515-26. 80. Singh, M., et al., Homeodomain transcription factors regulate BMP-2-induced osteoactivin transcription in osteoblasts. J Cell Physiol, 2012. 227(1): p. 390-9. 81. Ghoul-Mazgar, S., et al., Expression pattern of Dlx3 during cell differentiation in mineralized tissues. Bone, 2005. 37(6): p. 799-809. 82. Morasso, M.I., et al., Placental failure in mice lacking the homeobox gene Dlx3. Proc. Natl. Acad. Sci. USA, 1999. 96(1): p. 162-7. 83. Chui, A., et al., Homeobox gene distal-less 3 is expressed in proliferating and differentiating cells of the human placenta. Placenta, 2010. 31(8): p. 691-7. 84. Roberson, M.S., et al., A role for the homeobox protein Distal-less 3 in the activation of the glycoprotein hormone alpha subunit gene in choriocarcinoma cells. J Biol Chem, 2001. 276(13): p. 10016-24. 85. Chui, A., et al., Homeobox gene Distal-less 3 is a regulator of villous cytotrophoblast differentiation and its expression is increased in human idiopathic foetal growth restriction. J Mol Med (Berl), 2012. 90(3): p. 273-84. 86. Holland, M.P., et al., A role for CCAAT/enhancer-binding protein beta in the basal regulation of the distal-less 3 gene promoter in placental cells. Endocrinology, 2004. 145(3): p. 1096-105. 87. Liu, H.C., et al., Active corpus luteum function at pre-, peri- and postimplantation is essential for a viable pregnancy. Early Pregnancy, 1995. 1(4): p. 281-7. 88. Peng, L., et al., The murine 3beta-hydroxysteroid dehydrogenase (3beta-HSD) gene family: a postulated role for 3beta-HSD VI during early pregnancy. Mol Cell Endocrinol, 2002. 187(1-2): p. 213-21. 89. Khaliq, A., et al., Localisation of placenta growth factor (PIGF) in human term placenta. Growth Factors, 1996. 13(3-4): p. 243-50. 90. Vuorela, P., et al., Expression of Vascular Endothelial Growth Factor and Placenta Growth Factor in Human Placenta. Biol Reprod, 1997. 56(2): p. 489-94. 91. Li, S. and M.S. Roberson, Dlx3 and GCM-1 functionally coordinate the regulation of placental growth factor in human trophoblast-derived cells. J Cell Physiol, 2017. 232(10): p. 2900-2914. 92. Li, S. and M.S. Roberson, DLX3 interacts with GCM1 and inhibits its transactivation-stimulating activity in a homeodomain-dependent manner in human trophoblast-derived cells. Sci Rep, 2017. 7(1): p. 2009. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/70997 | - |
dc.description.abstract | 在人類胎盤滋養層細胞(Trophoblast cell)的發育中,GCM1 (Glial cells missing 1)轉錄因子扮演著極重要的角色,GCM1會藉由啟動下游不同的目標基因促使細胞性滋養層細胞(Cytotrophoblast, CTB)分化成融合滋養層細胞(Syncytiotrophoblast, STB)以及絨毛外滋養層細胞(Extravillous trophoblasts, EVT),同時也會影響到賀爾蒙的分泌等。cAMP/PKA此一訊息傳遞路徑會影響GCM1的轉錄活性,且可以藉由毛喉素(Forskolin)去啟動cAMP/PKA的路徑而強化GCM1的轉錄活性。胎盤生長因子(Placental growth factor, PGF)也是GCM1的目標基因之一,PGF屬於血管內皮生長因子(Vascular endothelial growth factor)家族的一員,在懷孕早期以及胎盤早期的發育之中也佔有一席之地。子癲前症(Preeclampsia)為一常見之孕婦疾病,其臨床症狀為蛋白尿及高血壓,在之前文獻指出子癲前症的患者中發現PGF在胎盤及血液中的表現量有明顯的降低。
屬於同源異型盒(Homeobox)家族的DLX3 (Distal-less 3)轉錄因子已知會參與在許多器官已及組織的發育中,而胎盤就是其中之一,有文獻指出DLX3會藉由與PGF啟動子結合進而調控PGF的表現量以及利用同源蛋白質區段 (Homeobox domain) 與GCM1有交互作用,因此,我們想了解DLX3會不會影響到GCM1調控PGF啟動子的能力,更進一步我們想知道DLX3是如何調控GCM1的活性。在我們的實驗結果中,藉由冷光報導基因活性檢測 (Luciferase reporter assay),我們證實文獻所說DLX3單獨表現會令PGF啟動子的活性上升是不正確的,但DLX3在擁有GCM1的環境之下會降低GCM1調控PGF的啟動子的能力。利用共同免疫沉澱法我們證實了DLX3及GCM1的確有交互作用,並且DLX3會藉由與GCM1的transactivation domain (TAD)做結合來影響GCM1的轉錄活性。更進一步,我們發現在人類絨毛膜癌BeWo細胞株中,加入毛喉素(Forskolin)的組別中,DLX3 mRNA表現量下降會讓GCM1的目標基因PGF及hCGβ mRNA的表現量上升。而後我們發現DLX3會降低cAMP/PKA 路徑中CREB-binding protein (CBP)與GCM1的交互作用及GCM1的乙醯化。綜合以上結果,我們發現DLX3會藉由與GCM1的交互作用來降低cAMP/PKA路徑中CBP與GCM1的交互作用降低GCM1的轉錄活性,進而影響到PGF啟動子的活性。 | zh_TW |
dc.description.abstract | GCM1 (Glial cells missing 1) transcription factor plays an important role in trophoblast cell differentiation during placental development. GCM1 activates downstream genes to promote the differentiation of cytotrophoblasts (CTBs) into syncytiotrophoblasts (STBs) and extravillous trophoblasts (EVTs). In addition, GCM1 regulates placental hormone synthesis. The cAMP/PKA signaling pathway, which can be activated by forskolin, is known to upregulate the transcription activity of GCM1. Placental growth factor (PGF), which is a member of vascular endothelial growth factor, has been shown to be a GCM1 target gene. PGF is expressed in trophoblast cells and insufficient serum level of PGF is associated with preeclampsia, which is a pregnancy complication with clinical features of gestational hypertension and proteinuria.
The transcription factor Distal-less 3 (DLX3) is an essential regulator in many tissues and organs, and in placental development. Previous studies have shown that DLX3 regulates PGF expression and interacts with GCM1. Here we investigated whether DLX3 is involved in GCM1-mediated PGF gene expression, and how DLX3 regulates GCM1 transcriptional activity. We showed that DLX3 down-regulates GCM1-mediated PGF promoter activity. Co-immunoprecipitation demonstrated that DLX3 interacts with GCM1 transactivation domain and impairs GCM1 transcriptional activity. Correspondingly, DLX3 knockdown in the BeWo choriocarcinoma cell line enhanced the stimulation of PGF and hCGβ by forskolin, which can be attributed to suppression of CBP-mediated GCM1 acetylation and activation by GCM1-DLX3 interaction. This study reveals a novel mechanism for regulation of PGF by GCM1 and DLX3 in placenta. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T04:47:38Z (GMT). No. of bitstreams: 1 ntu-107-R05b46026-1.pdf: 1949603 bytes, checksum: 69d2c80c3148b6f27b6ad6b417eccf9a (MD5) Previous issue date: 2018 | en |
dc.description.tableofcontents | 目錄 I
目錄圖表 III 中文摘要 IV 英文摘要 VI 第一章 緒論 1.1 胎盤 1 1.2 GCM1轉錄因子 4 1.3 胎盤生長因子 7 1.4 DLX3 轉錄因子 10 1.5 研究動機 13 第二章 材料與方法 2.1質體重組構築 14 2.2細胞株培養及轉染 18 2.3冷光報導基因活性檢測 19 2.4 SDS聚丙烯醯胺凝膠電泳與西方墨點法 20 2.5細胞蛋白質萃取及共同免疫沉澱法 21 2.6內生性共同免疫沉澱法 21 2.7 RNA干擾及慢病毒感染 23 2.8定量及時聚合酶連鎖反應 24 第三章 實驗結果 3.1 DLX3轉錄因子降低GCM1對PGF啟動子的調控能力 26 3.2 DLX3轉錄因子降低GCM1轉錄因子的轉錄活性 26 3.3 DLX3轉錄因子與GCM1轉錄因子的交互作用 27 3.4 DLX3轉錄因子與GCM1轉錄因子的結合位置 28 3.5 DLX3轉錄因子影響GCM1轉錄因子轉錄活性之機制 29 3.6 DLX3轉錄因子對於GCM1轉錄因子下游基因的影響 30 3.7 DLX3轉錄因子對於CBP調控GCM1活性的影響 31 第四章 討論與總結 32 第五章 圖表 37 第六章 參考文獻 50 | |
dc.language.iso | zh-TW | |
dc.title | GCM1及DLX3調控胎盤中PGF基因機制之探討 | zh_TW |
dc.title | Regulation of PGF gene expression by GCM1 and DLX3 in placenta | en |
dc.type | Thesis | |
dc.date.schoolyear | 106-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 張震東,張功耀,黃娟娟 | |
dc.subject.keyword | GCM1,DLX3,PGF,胎盤, | zh_TW |
dc.subject.keyword | GCM1,DLX3,PGF,Placenta, | en |
dc.relation.page | 59 | |
dc.identifier.doi | 10.6342/NTU201801992 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2018-08-01 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生化科學研究所 | zh_TW |
顯示於系所單位: | 生化科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-107-1.pdf 目前未授權公開取用 | 1.9 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。